Compound: Idelalisib

Drug Target: PI3Kdelta

Drug Target pathway: PI3K/MTOR signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.